1
|
Baskerville S and Bartel DP: Microarray
profiling of microRNAs reveals frequent coexpression with
neighboring miRNAs and host genes. RNA. 11:241–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Selbach M, Schwanhausser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gottwein E and Cullen BR: Viral and
cellular microRNAs as determinants of viral pathogenesis and
immunity. Cell Host Microbe. 3:375–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Segura MF, Hanniford D, Menendez S, et al:
Aberrant miR-182 expression promotes melanoma metastasis by
repressing FOXO3 and microphthalmia-associated transcription
factor. Proc Natl Acad Sci USA. 106:1814–1819. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang Y, Lee AT, Ma JZ, et al: Profiling
microRNA expression in hepatocellular carcinoma reveals
microRNA-224 up-regulation and apoptosis inhibitor-5 as a
microRNA-224-specific target. J Biol Chem. 283:13205–13215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Sato F, Hatano E, Kitamura K, et al:
MicroRNA profile predicts recurrence after resection in patients
with hepatocellular carcinoma within the milan criteria. PLoS One.
6:e164352011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ladeiro Y, Couchy G, Balabaud C, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Pineau P, Volinia S, McJunkin K, et al:
miR-221 overexpression contributes to liver tumorigenesis. Proc
Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar :
|
10
|
Chen RX, Xia YH, Xue TC and Ye SL:
Suppression of microRNA-96 expression inhibits the invasion of
hepatocellular carcinoma cells. Mol Med Rep. 5:800–804. 2012.
|
11
|
Wang J, Li J, Shen J, Wang C, Yang L and
Zhang X: MicroRNA-182 downregulates metastasis suppressor 1 and
contributes to metastasis of hepatocellular carcinoma. BMC Cancer.
12:2272012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Dong ZZ, Yao DF, Wu W, et al: Correlation
between epigenetic alterations in the insulin growth factor-II gene
and hepatocellular carcinoma. Chin J Hepatol. 20:593–597. 2012.In
Chinese.
|
13
|
Scharf JG, Schmidt-Sandte W, Pahernik SA,
Ramadori G, Braulke T and Hartmann H: Characterization of the
insulin-like growth factor axis in a human hepatoma cell line
(PLC). Carcinogenesis. 19:2121–2128. 1998. View Article : Google Scholar
|
14
|
Gong Y, Cui L and Minuk GY: The expression
of insulin-like growth factor binding proteins in human
hepatocellular carcinoma. Mol Cell Biochem. 207:101–104. 2000.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Gray SG, Eriksson T, Ekstrom C, et al:
Altered expression of members of the IGF-axis in hepatoblastomas.
Br J Cancer. 82:1561–1567. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xu D, He X, Chang Y, et al: Inhibition of
miR-96 expression reduces cell proliferation and clonogenicity of
HepG2 hepatoma cells. Oncol Rep. 29:653–661. 2013.
|
17
|
Yin Y, Li M, Li H, et al: Expressions of 6
microRNAs in prostate cancer. Natl J Androl. 16:599–605. 2010.In
Chinese.
|
18
|
Nussbaum T, Samarin J, Ehemann V, et al:
Autocrine insulin-like growth factor-II stimulation of tumor cell
migration is a progression step in human hepatocarcinogenesis.
Hepatology. 48:146–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Aleem E, Nehrbass D, Klimek F, Mayer D and
Bannasch P: Upregulation of the insulin receptor and type I
insulin-like growth factor receptor are early events in
hepatocarcinogenesis. Toxicol Pathol. 39:524–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Jalvy-Delvaille S, Maurel M, Majo V, et
al: Molecular basis of differential target regulation by miR-96 and
miR-182: the Glypican-3 as a model. Nucleic Acids Res.
40:1356–1365. 2012. View Article : Google Scholar :
|
21
|
Gu C, Li X, Tan Q, Wang Z, Chen L and Liu
Y: MiR-183 family regulates chloride intracellular channel 5
expression in inner ear hair cells. Toxicol In Vitro. 27:486–491.
2013. View Article : Google Scholar
|
22
|
Henke JI, Goergen D, Zheng J, et al:
microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO
J. 27:3300–3310. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Villanueva RA, Jangra RK, Yi M, Pyles R,
Bourne N and Lemon SM: miR-122 does not modulate the elongation
phase of hepatitis C virus RNA synthesis in isolated replicase
complexes. Antiviral Res. 88:119–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Norman KL and Sarnow P: Modulation of
hepatitis C virus RNA abundance and the isoprenoid biosynthesis
pathway by microRNA miR-122 involves distinct mechanisms. J Virol.
84:666–670. 2010. View Article : Google Scholar :
|
25
|
Jopling CL: Regulation of hepatitis C
virus by microRNA-122. Biochem Soc Trans. 36:1220–1223. 2008.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Tsai NP, Lin YL and Wei LN: MicroRNA
mir-346 targets the 5′-untranslated region of receptor-interacting
protein 140 (RIP140) mRNA and up-regulates its protein expression.
Biochem J. 424:411–418. 2009. View Article : Google Scholar : PubMed/NCBI
|